• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1%阿仑膦酸盐和芦荟凝胶作为慢性牙周炎伴Ⅱ度根分叉病变患者的局部宿主调节剂:一项随机对照临床试验。

One percent alendronate and aloe vera gel local host modulating agents in chronic periodontitis patients with class II furcation defects: A randomized, controlled clinical trial.

作者信息

Ipshita Sahu, Kurian Ida G, Dileep Pankaj, Kumar Shatrughan, Singh Priyanka, Pradeep Avani R

机构信息

Department of Periodontology, Government Dental College and Research Institute, Bangalore, Karnataka, India.

Department of Medicine, Employee's State Insurance Postgraduate Institute of Medical Science and Research, Bangalore, Karnataka, India.

出版信息

J Investig Clin Dent. 2018 Aug;9(3):e12334. doi: 10.1111/jicd.12334. Epub 2018 May 2.

DOI:10.1111/jicd.12334
PMID:29722166
Abstract

AIM

Alendronate (ALN) has antiresorptive and osteostimulative properties. The major component of aloe vera (AV) gel is acemannan, which has been found to have osteogenic properties. The aim of the present study is to explore the effectiveness of 1% ALN and AV gel as an adjunct to scaling and root planing (SRP) in chronic periodontitis patients with class II furcation defects.

METHODS

Ninety volunteers were randomly assigned to three treatment groups: (a) SRP plus placebo gel; (b) SRP plus 1% ALN gel; and (c) SRP plus AV gel. Clinical and radiographic parameters were recorded at baseline and at 6 and 12 months.

RESULTS

The mean probing depth reduction and relative horizontal clinical attachment level (CAL) and relative vertical CAL gains were greater in the ALN group than in the AV and placebo groups at 6 and 12 months. Furthermore, a significantly greater mean percentage of defect depth reduction (DDR) was found in the ALN group (38.09 ± 9.53, 44.86 ± 6.29) than the AV groups (11.94 ± 15.10, 14.59 ± 25.49) at 6 and 12 months, respectively.

CONCLUSION

ALN showed significant improvement in all clinical parameters, along with greater DDR, compared to AV in the treatment of class II furcation defects as an adjunct to SRP.

摘要

目的

阿仑膦酸盐(ALN)具有抗吸收和骨刺激特性。芦荟(AV)凝胶的主要成分是乙酰化甘露聚糖,已发现其具有成骨特性。本研究的目的是探讨1%ALN和AV凝胶作为慢性牙周炎Ⅱ度根分叉病变患者龈下刮治和根面平整(SRP)辅助治疗手段的有效性。

方法

90名志愿者被随机分为三个治疗组:(a)SRP加安慰剂凝胶;(b)SRP加1%ALN凝胶;(c)SRP加AV凝胶。在基线、6个月和12个月时记录临床和影像学参数。

结果

在6个月和12个月时,ALN组的平均探诊深度减少、相对水平临床附着水平(CAL)和相对垂直CAL增加均大于AV组和安慰剂组。此外,在6个月和12个月时,ALN组的平均缺损深度减少百分比(DDR)(分别为38.09±9.53、44.86±6.29)显著高于AV组(分别为11.94±15.10、14.59±25.49)。

结论

在治疗Ⅱ度根分叉病变作为SRP辅助手段时,与AV相比,ALN在所有临床参数上均显示出显著改善,同时DDR更高。

相似文献

1
One percent alendronate and aloe vera gel local host modulating agents in chronic periodontitis patients with class II furcation defects: A randomized, controlled clinical trial.1%阿仑膦酸盐和芦荟凝胶作为慢性牙周炎伴Ⅱ度根分叉病变患者的局部宿主调节剂:一项随机对照临床试验。
J Investig Clin Dent. 2018 Aug;9(3):e12334. doi: 10.1111/jicd.12334. Epub 2018 May 2.
2
1% alendronate gel as local drug delivery in the treatment of Class II furcation defects: a randomized controlled clinical trial.1% 阿伦膦酸钠凝胶作为局部药物输送治疗 II 类分叉缺损:一项随机对照临床试验。
J Periodontol. 2013 Mar;84(3):307-15. doi: 10.1902/jop.2012.110729. Epub 2012 May 3.
3
Clinical efficacy of 1% alendronate gel as a local drug delivery system in the treatment of chronic periodontitis: a randomized, controlled clinical trial.1%阿仑膦酸钠凝胶作为局部药物递送系统治疗慢性牙周炎的临床疗效:一项随机、对照临床试验。
J Periodontol. 2012 Jan;83(1):11-8. doi: 10.1902/jop.2011.110091. Epub 2011 May 4.
4
Comparative evaluation of subgingivally-delivered 1% metformin and Aloe vera gel in the treatment of intrabony defects in chronic periodontitis patients: A randomized, controlled clinical trial.比较龈下给予1%二甲双胍和芦荟凝胶治疗慢性牙周炎患者骨内缺损的疗效:一项随机对照临床试验。
J Investig Clin Dent. 2018 Aug;9(3):e12324. doi: 10.1111/jicd.12324. Epub 2018 Jul 6.
5
Clinical efficacy of 1% alendronate gel in adjunct to mechanotherapy in the treatment of aggressive periodontitis: a randomized controlled clinical trial.1%阿仑膦酸钠凝胶辅助机械疗法治疗侵袭性牙周炎的临床疗效:一项随机对照临床试验。
J Periodontol. 2012 Jan;83(1):19-26. doi: 10.1902/jop.2011.110206. Epub 2011 May 24.
6
Local drug delivery of alendronate gel for the treatment of patients with chronic periodontitis with diabetes mellitus: a double-masked controlled clinical trial.局部给予阿仑膦酸钠凝胶治疗伴糖尿病的慢性牙周炎患者的疗效:一项双盲对照临床试验。
J Periodontol. 2012 Oct;83(10):1322-8. doi: 10.1902/jop.2012.110292. Epub 2012 Jan 20.
7
Role of 1% alendronate gel as adjunct to mechanical therapy in the treatment of chronic periodontitis among smokers.1%阿仑膦酸盐凝胶作为辅助机械治疗手段在吸烟者慢性牙周炎治疗中的作用
J Appl Oral Sci. 2017 May-Jun;25(3):243-249. doi: 10.1590/1678-7757-2016-0201.
8
Mandibular Degree II Furcation Defects Treatment With Platelet-Rich Fibrin and 1% Alendronate Gel Combination: A Randomized Controlled Clinical Trial.富血小板纤维蛋白和 1%阿仑膦酸钠凝胶联合治疗下颌 II 度分根区缺损的随机对照临床试验。
J Periodontol. 2017 Mar;88(3):250-258. doi: 10.1902/jop.2016.160269. Epub 2016 Oct 7.
9
Boric acid gel as local drug delivery in the treatment of class II furcation defects in chronic periodontitis: a randomized, controlled clinical trial.硼酸凝胶作为局部给药治疗慢性牙周炎Ⅱ度根分叉病变:一项随机对照临床试验。
J Investig Clin Dent. 2018 Feb;9(1). doi: 10.1111/jicd.12279. Epub 2017 Jun 20.
10
1.2% Rosuvastatin and 1.2% Atorvastatin Gel Local Drug Delivery and Redelivery in the Treatment of Class II Furcation Defects: A Randomized Controlled Clinical Trial.1.2%瑞舒伐他汀和 1.2%阿托伐他汀凝胶局部药物递送和再递送治疗 II 类分叉缺损:一项随机对照临床试验。
J Periodontol. 2017 Mar;88(3):259-265. doi: 10.1902/jop.2016.160399. Epub 2016 Oct 7.

引用本文的文献

1
Clinical effectiveness of aloe vera gel as an adjunct to mechanical debridement in patients with periodontitis: A systematic review and meta-analysis.芦荟凝胶作为辅助手段用于牙周炎患者机械清创的临床疗效:一项系统评价和荟萃分析。
J Adv Periodontol Implant Dent. 2025 Jan 20;17(1):15-25. doi: 10.34172/japid.2025.002. eCollection 2025 Mar.
2
From Basic Science to Clinical Practice: A Review of Current Periodontal/Mucogingival Regenerative Biomaterials.从基础科学到临床实践:当前牙周/黏骨膜再生生物材料的综述。
Adv Sci (Weinh). 2024 May;11(17):e2308848. doi: 10.1002/advs.202308848. Epub 2024 Feb 21.
3
Exploring the Antibacterial Potential of Konjac Glucomannan in Periodontitis: Animal and In Vitro Studies.
探讨魔芋葡甘聚糖在牙周炎中的抗菌潜力:动物和体外研究。
Medicina (Kaunas). 2023 Oct 6;59(10):1778. doi: 10.3390/medicina59101778.
4
Impact of local drug delivery and natural agents as new target strategies against periodontitis: new challenges for personalized therapeutic approach.局部药物递送和天然药物作为抗牙周炎新靶向策略的影响:个性化治疗方法面临的新挑战。
Ther Adv Chronic Dis. 2023 Sep 13;14:20406223231191043. doi: 10.1177/20406223231191043. eCollection 2023.
5
Tau-Marin Mucoadhesive Gel for Prevention and Treatment of Gum Diseases.用于预防和治疗牙龈疾病的Tau-Marin粘膜粘附凝胶。
Gels. 2023 Jul 27;9(8):607. doi: 10.3390/gels9080607.
6
A New Biomaterial Derived from -Acemannan from Basic Studies to Clinical Application.一种源自乙酰甘露聚糖的新型生物材料:从基础研究到临床应用
Pharmaceutics. 2023 Jul 9;15(7):1913. doi: 10.3390/pharmaceutics15071913.
7
Local drug delivery in the treatment of furcation defects in periodontitis: a systematic review.局部药物输送治疗牙周炎的分叉缺损:系统评价。
Clin Oral Investig. 2023 Mar;27(3):955-970. doi: 10.1007/s00784-023-04871-0. Epub 2023 Feb 2.
8
Effects of aloe-emodin on alveolar bone in -induced periodontitis rat model: a pilot study.芦荟大黄素对诱导性牙周炎大鼠模型牙槽骨的影响:一项初步研究。
J Periodontal Implant Sci. 2022 Oct;52(5):383-393. doi: 10.5051/jpis.2104060203.
9
Added effect of 1% topical alendronate in intra-bony and inter-radicular defects as part of step II periodontal therapy: a systematic review with meta-analysis and trial sequential analysis.作为牙周治疗第二阶段的一部分,在骨内和根间缺损部位局部使用 1%的阿仑膦酸钠的附加疗效:一项系统评价和荟萃分析及试验序贯分析。
BMC Oral Health. 2022 Jan 21;22(1):15. doi: 10.1186/s12903-022-02044-1.
10
Home Oral Care of Periodontal Patients Using Antimicrobial Gel with Postbiotics, Lactoferrin, and Aloe Barbadensis Leaf Juice Powder vs. Conventional Chlorhexidine Gel: A Split-Mouth Randomized Clinical Trial.使用含后生元、乳铁蛋白和库拉索芦荟叶汁粉的抗菌凝胶与传统氯己定凝胶对牙周病患者进行家庭口腔护理:一项半口随机临床试验。
Antibiotics (Basel). 2022 Jan 17;11(1):118. doi: 10.3390/antibiotics11010118.